Plasma β-amyloid in Alzheimer’s disease and vascular disease

Implementation of amyloid biomarkers in clinical practice would be accelerated if such biomarkers could be measured in blood. We analyzed plasma levels of Aβ42 and Aβ40 in a cohort of 719 individuals (the Swedish BioFINDER study), including patients with subjective cognitive decline (SCD), mild cogn...

Descripción completa

Detalles Bibliográficos
Autores principales: Janelidze, Shorena, Stomrud, Erik, Palmqvist, Sebastian, Zetterberg, Henrik, van Westen, Danielle, Jeromin, Andreas, Song, Linan, Hanlon, David, Tan Hehir, Cristina A., Baker, David, Blennow, Kaj, Hansson, Oskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886210/
https://www.ncbi.nlm.nih.gov/pubmed/27241045
http://dx.doi.org/10.1038/srep26801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886210/
https://www.ncbi.nlm.nih.gov/pubmed/27241045
http://dx.doi.org/10.1038/srep26801

Ejemplares similares